Results 231 to 240 of about 9,412 (255)

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study.

InflammoPharmacology
Mostafa M. Bahaa, S. Hegazy, Maha M. Maher, Monir M. Bahgat, S. El-Haggar   +4 more
semanticscholar   +1 more source

Mesalamine

1998
Alekha K. Dash, Harry G. Brittain
openaire   +1 more source

Mesalamine-induced Bradycardia

American Journal of Gastroenterology, 2017
Michael Krzyzak, Stephen Mulrooney
openaire   +2 more sources

Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.

International Immunopharmacology
S. El-Haggar, S. Hegazy, Maha M. Maher, Monir M. Bahgat, Mostafa M. Bahaa   +4 more
semanticscholar   +1 more source

A Pharmacokinetic and Scintigraphic Comparison of MMX™ mesalamine and Delayed-Release mesalamine

American Journal of Gastroenterology, 2008
David B. Pierce, R Joseph, Heather Wray, Mary Palmen   +3 more
openaire   +2 more sources

Peri-myocarditis caused by topical rectal mesalamine

Clinical Journal of Gastroenterology, 2021
B. Koslowsky, A. Orlev
semanticscholar   +1 more source

Mesalamine-Induced Myopericarditis

American Journal of Gastroenterology, 2018
Jessica McKee, John E. Walker, Marika Bergenstock   +2 more
openaire   +2 more sources

Mesalamine Induced Pericarditis

American Journal of Gastroenterology, 2012
Sunbal Zafar, Supreet Sethi, Farshad Aduli, Gaurav Syal   +3 more
openaire   +2 more sources

Efficacy of Mesalamine in Irritable Bowel Syndrome

Clinical Gastroenterology and Hepatology, 2023
Cong, Dai, Min, Jiang, Yu-Hong, Huang
openaire   +2 more sources

Mesalamine-Associated Sinus Bradycardia

American Journal of Therapeutics, 2019
Jennifer Kostela, Jite Wanogho, Adewale Odofin, Joseph Mattana, Mohammed Elsadany   +4 more
openaire   +2 more sources